ResearcherChinese University of Hong KongActive in the last 2 years
Xin Wang
Matched on ORCID iD 0000-0002-5122-2418; OpenAlex author ID A5100327957. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 39
2020: 3 papers · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper
Papers 6
- Cell-Selective Delivery of RIBOTACs via an Anti-EGFR Nanobody for Pancreatic Cancer Treatment. Last author DOI 10.1002/advs.76575↗
- Dual inhibition of FACT and RRM2 suppresses the progression of pancreatic ductal adenocarcinoma driven by the oncohistone H2BG53D. Co-author DOI 10.1016/j.celrep.2025.116596↗
- An Exosome-based Transcriptomic Signature for Noninvasive, Early Detection of Patients With Pancreatic Ductal Adenocarcinoma: A Multicenter Cohort Study. Co-author DOI 10.1053/j.gastro.2022.06.090↗
- The H2BG53D oncohistone directly upregulates ANXA3 transcription and enhances cell migration in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41392-020-00219-2↗
- Unsupervised class discovery in pancreatic ductal adenocarcinoma reveals cell-intrinsic mesenchymal features and high concordance between existing classificati… Co-author DOI 10.1038/s41598-019-56826-9↗
- A Network-Based Approach for Identification of Subtype-Specific Master Regulators in Pancreatic Ductal Adenocarcinoma. Last author DOI 10.3390/genes11020155↗
Closest collaborators
The 25 strongest of 39 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Ajay Goel · 2 shared papers, 2022–2026 · strength 0.36
- Kui Ming Chan · 2 shared papers, 2020–2025 · strength 0.32
- Paper Dual inhibition of FACT and RRM2 suppresses the progression of pancreatic ductal adenocarcinoma driven by the oncohisto… DOI 10.1016/j.celrep.2025.116596↗
- Paper The H2BG53D oncohistone directly upregulates ANXA3 transcription and enhances cell migration in pancreatic ductal adeno… DOI 10.1038/s41392-020-00219-2↗
- Yi Ching Esther Wan · 2 shared papers, 2020–2025 · strength 0.32
- Paper Dual inhibition of FACT and RRM2 suppresses the progression of pancreatic ductal adenocarcinoma driven by the oncohisto… DOI 10.1016/j.celrep.2025.116596↗
- Paper The H2BG53D oncohistone directly upregulates ANXA3 transcription and enhances cell migration in pancreatic ductal adeno… DOI 10.1038/s41392-020-00219-2↗
- Hang Jiang · 1 shared paper, 2026 · strength 0.25
- Tianli Luo · 1 shared paper, 2026 · strength 0.25
- Landon Long Chan · 1 shared paper, 2025 · strength 0.21
- Tiantian Qin · 1 shared paper, 2025 · strength 0.21
- Yuchen Zhang · 1 shared paper, 2020 · strength 0.19
- John S. Bolton · 1 shared paper, 2022 · strength 0.11
- Derek Cridebring · 1 shared paper, 2022 · strength 0.11
- Kota Nakamura · 1 shared paper, 2022 · strength 0.11
- In Woong Han · 1 shared paper, 2022 · strength 0.11
- Suguru Yamada · 1 shared paper, 2022 · strength 0.11
- Satoshi Nishiwada · 1 shared paper, 2022 · strength 0.11
- Scott A. Celinski · 1 shared paper, 2022 · strength 0.11
- Eunsung Jun · 1 shared paper, 2022 · strength 0.11
- Geeta G. Sharma · 1 shared paper, 2022 · strength 0.11
- Carlos Roberto Becerra · 1 shared paper, 2022 · strength 0.11
- Yasuhiro Kodera · 1 shared paper, 2022 · strength 0.11
- Haiyong Han · 1 shared paper, 2022 · strength 0.11
- Joon Oh Park · 1 shared paper, 2022 · strength 0.11
- Erkut Hasan Borazanci · 1 shared paper, 2022 · strength 0.11
- Daniel D. Von Hoff · 1 shared paper, 2022 · strength 0.11
- L. Bengt van Rijssen · 1 shared paper, 2020 · strength 0.08
- Hanneke W. Wilmink · 1 shared paper, 2020 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.